Companies: 10,795·Total market cap: $144.5T
ResMed Inc.

ResMed Inc.

RMDNYSEHealthcare● Active
$194.41
$-1.63(-0.83%)
Market Cap$28.2B
P/E Ratio—
52W High$293.81
52W Low$180.27
Overview

ResMed Inc. (RMD) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

RMD · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.21B▲ +407.4% vs prior year
FY · as of Jun 30, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$1.21B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+407.4%
vs prior fiscal year
Latest Quarter
$1.66B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$1.21BCash on Hand
Total Debt$851.8MTotal Debt
Net Cash / Net Debt+$357.6MNet Cash Position
Cash vs Debt Ratio
Cash 59%Debt 41%

ResMed Inc. has a net cash position of $357.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$1.21B − $851.8M = +$357.6M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
RMD annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$1.21B+407.4%
Jun 30, 2024$238.4M+4.6%
Jun 30, 2023$227.9M-16.7%
Jun 30, 2022$273.7M-7.3%
Jun 30, 2021$295.3M-36.2%
RMD cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
ResMed Inc.
ResMed Inc.YOU
RMD
$1.21B4.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

ResMed Inc. (RMD) cash on hand as of June 30, 2025 is $1.21B, comprising $1.21B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as ResMed Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as ResMed Inc. cash reserves or cash position.

ResMed Inc. annual cash on hand history shows increased +407.4% in 2025: increased +407.4% in 2025. ResMed Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

ResMed Inc. carries total debt of $851.8M against cash of $1.21B, resulting in a net cash position of +$357.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

RMD cash on hand · 5 questions

As of June 30, 2025, ResMed Inc. (RMD) has $1.21B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.21B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $1.66B. Data sourced from the annual 10-K filing via FMP.

RMD cash on handRMD cash reservesRMD cash 2025how much cash does RMD have

▸ Source: FMP /balance-sheet-statement · US GAAP · ResMed Inc. · ResMed Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025